Key Advisory Panel Member Concedes It Is Medically Plausible That Testosterone Replacement Therapy Can Be Associated With Heart Attacks / Strokes Side Effects
SUMMARY: In mid-September 2014 members of two FDA advisory panels in a joint meeting considered the issue of whether the popular testosterone products Axiron, AndroGel, and Testim, as well as other so-called “Low-T” drugs, are safe.
We have to wait to see what regulatory action the FDA will take, if any, concerning the possible increased risks of heart attacks and strokes that some link to these testosterone replacement therapy drugs.
The outcome of their discussions was essentially that for most current users of Axiron, AndroGel, Testim, and other “Low-T” drugs we do not know and cannot know if they cause such cardiovascular side effects because no safety study has been done, yet.[Read this article in full at original source]
Strictly Confidential, No Obligation